Successful treatment of systemic mastocytosis with acute myeloid leukemia: a case report
(Source: Annals of Hematology)
Source: Annals of Hematology - October 1, 2023 Category: Hematology Source Type: research
One disease, two faces: clonally-related AML and MPDCP with skin involvement
(Source: Annals of Hematology)
Source: Annals of Hematology - October 1, 2023 Category: Hematology Source Type: research
Real-life experience with luspatercept in transfusion-dependent β-thalassemia
(Source: Annals of Hematology)
Source: Annals of Hematology - October 1, 2023 Category: Hematology Source Type: research
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
(Source: Annals of Hematology)
Source: Annals of Hematology - October 1, 2023 Category: Hematology Source Type: research
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?
(Source: Annals of Hematology)
Source: Annals of Hematology - October 1, 2023 Category: Hematology Source Type: research
Clinical features and prognostic risk prediction of adult hemophagocytic lymphohistiocytosis: a 9-year retrospective study
AbstractHemophagocytic lymphohistiocytosis (HLH) has a low incidence and high mortality. In order to improve our understanding of the clinical features and prognostic risk factors of adult HLH, we analyzed the clinical characteristics and prognostic risk factors of adult HLH and developed a prognostic model to predict the overall survival (OS) of adult HLH. The clinical characteristics and survival statistics of adult patients with HLH identified at The Second Affiliated Hospital of Chongqing Medical University between February 2012 and October 2020 were retrospectively analyzed to constitute the primary cohort, while pati...
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
Association between anemia and depression: results from NHANES 2005 –2018 and mendelian randomization analyses
ConclusionsOur findings do not support a causal association between anemia and depression. The association between hemoglobin concentration and depression was not statistically significant either. (Source: Annals of Hematology)
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
Single-agent brentuximab vedotin as frontline therapy for Hodgkin lymphoma patients with severe hepatic impairment: a report of two cases
(Source: Annals of Hematology)
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation
(Source: Annals of Hematology)
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
Inherited macrothrombocytopenia due to a novel splice donor site mutation in ITGB3
(Source: Annals of Hematology)
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung
(Source: Annals of Hematology)
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
One disease, two faces: clonally-related AML and MPDCP with skin involvement
(Source: Annals of Hematology)
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
Real-life experience with luspatercept in transfusion-dependent β-thalassemia
(Source: Annals of Hematology)
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?
(Source: Annals of Hematology)
Source: Annals of Hematology - September 9, 2023 Category: Hematology Source Type: research
Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study
In conclusion, our study demonstrated that R-R AML patients in NR or with concomitant extramedullary leukemia can benefit from allo-HSCT, regardless of leukemia burden at the time of transplantation. Patients who experience cGVHD after allo-HS CT may have lower relapse rate due to enhanced graft-versus-leukemia (GVL) effects, but cGVHD should be controlled at mild to moderate level to avoid life-threatening complications. (Source: Annals of Hematology)
Source: Annals of Hematology - September 8, 2023 Category: Hematology Source Type: research
